Health
Tocilizumab, Rheumatoid Arthritis Medication, Found to Reduce Severe COVID-19 Deaths – Science Times
Clinical trials in 12 public and private hospitals in India headed by the University of Bristol and Medanta Institute of Education and Research add evidence to…
India, one of the most ethnically diverse countries, conducted the first randomized trials on the use of rheumatoid arthritis medication, Tocilizumab, to reduce death risks in severe COVID-19 cases.
Headed by researchers from the University of Bristol and Medanta Institute of Education and Research, they explained that data gathered from clinical trials add to existing evidence that supports the use of Tocilizumab, an anti-inflammatory drug, in critically ill patients.
Science Behind Tocilizumab…
-
Noosa News21 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News22 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General22 hours agoLabor to squeeze public service, sparking warnings of job losses
-
General8 hours agoGrieving parents of 4yo boy who drowned in Officer suing Melbourne Water, Cardinia council